165 filings
Page 5 of 9
8-K
h2996d
28 Feb 20
Other Events
12:00am
8-K
qln1 tk0cxm
27 Feb 20
TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2019 Financial Results and Provides Corporate Update
4:13pm
8-K
jtw0zem qop09
10 Feb 20
Regulation FD Disclosure
8:15am
8-K
vtcimfkq
7 Feb 20
TRACON Pharmaceuticals Announces Change to Nasdaq Capital Market
8:17am
8-K
62gym308s
13 Jan 20
Other Events
8:20am
8-K
xqg bxmjh
3 Jan 20
Results of Operations and Financial Condition
5:13pm
8-K
pk6ctg4hqpowhdnuh
20 Dec 19
Entry into a Material Definitive Agreement
7:14am
8-K
od8an5
25 Nov 19
Other Events
4:18pm
8-K
dwga10ytu5 om
6 Nov 19
Amendments to Articles of Incorporation or Bylaws
5:08pm
8-K
7ynrm
5 Nov 19
TRACON Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Corporate Update
4:13pm
8-K
j3e220
21 Oct 19
Common Stock Purchase Agreement
8:20am
8-K
raw 3nhdn3g1s
17 Oct 19
Other Events
12:00am
8-K
hfmcpt9oy91us6
20 Sep 19
Departure of Directors or Certain Officers
4:12pm
8-K
sz29o8fi4 oxhtnrzh
6 Sep 19
Other Events
4:18pm
8-K
skhxtha309q03k7ln
16 Aug 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:01pm
8-K
1rgeq ybn5k
7 Aug 19
Results of Operations and Financial Condition
4:11pm
8-K
oftjbm23
14 Jun 19
Departure of Directors or Certain Officers
4:11pm
8-K
e6ci9 bzfc7
31 May 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:10pm
8-K
dwakb
14 May 19
Results of Operations and Financial Condition
4:14pm
8-K
0em1hds o8iybbm4j7
12 Apr 19
TRACON Pharmaceuticals Announces Termination of Phase 3 TAPPAS Trial Based on the Recommendation of the Independent Data Monitoring Committee
7:04am